Top Story

Lifestyle-induced weight loss produces improvement in NASH, fibrosis

Lifestyle-induced weight loss produces improvement in NASH, fibrosis
April 25, 2015

VIENNA — Weight loss induced through year-long lifestyle intervention independently predicted improvement in non-alcoholic steatohepatitis, non-alcoholic steatosis and fibrosis, according to a study presented at the 2015 International Liver Congress.

“Weight loss induced by a comprehensive lifestyle program during 12 months produces important changes in most of the histological NASH-related features,” Eduardo Vilar-Gomez, MD, from the National Institute of Gastroenterology, Havana, Cuba, said during his presentation. “Our findings support the current recommendation for weight loss lifestyle modification as the first-line therapy for patients with NASH.”

Meeting News Coverage

Cardiovascular risks correlate with increasing levels of steatohepatitis, cirrhosis

April 25, 2015
VIENNA — Cardiovascular risks increased with rising severity of non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and cirrhosis, according to a…
VIDEO: PCOS Awareness Symposium educates patients and health care providers Meeting News CoverageVideo

VIDEO: PCOS Awareness Symposium educates patients and health care providers

April 24, 2015
Sasha Ottey, MHA, MT (ASCP), founder and executive director of PCOS Challenge, appeals to endocrinologists and other providers to learn about PCOS and make the…
In the Journals

Calorie restriction with exercise improves insulin sensitivity

April 24, 2015
Adults with overweight who combined calorie restriction with exercise for weight loss had greater improvements in insulin sensitivity than those who only restricted…
VIDEO: Managing PCOS requires commitment to being healthy Meeting News CoverageVideo

VIDEO: Managing PCOS requires commitment to being healthy

April 24, 2015
Katherine Sherif, MD, director of Jefferson Women’s Primary Care and vice chair of the Department of Medicine at Thomas Jefferson University Hospitals in…
More News Headlines »
CME
Obesity Consults: Volume 2, Number 2 Obesity Forum 2014 Highlights

Obesity Consults: Volume 2, Number 2
Obesity Forum 2014 Highlights

This activity is supported by educational grants from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc; Eisai, Inc.; Novo Nordisk; Vivus, Inc.

Management of obesity is complex, factoring in psychological, environmental, and physiologic causes. Treatment options…
More »
Meeting News Coverage Video
VIDEO: Managing PCOS requires commitment to being healthy

VIDEO: Managing PCOS requires commitment to being healthy

April 24, 2015
Katherine Sherif, MD, director of Jefferson Women’s Primary Care and vice chair of the Department of Medicine at…
More »
CME
Obesity Consults: Volume 2, Number 4 Obesity and the Cardiovascular System

Obesity Consults: Volume 2, Number 4
Obesity and the Cardiovascular System

This activity is supported by an educational grant from Eisai, Inc. and Vivus, Inc.

Obesity is associated with a wide range of comorbid conditions, including diabetes, hypertension, sleep apnea, and…
More »
Current Issues
View the Current Issues
morganatic-roan